Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPMI AV-133 Prodromal Imaging
NCT07265596Phase 2Recruiting
- Sponsor
- The Michael J. Fox Foundation for Parkinson's Research
- Start
- Oct 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of Florbenazine F-18 in Parkinson's disease (PD), sponsored by The Michael J. Fox Foundation for Parkinson's Research. Started Oct 2023; status: recruiting.
02
Drugs
Florbenazine F-18
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07265596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265596.